rosuvastatin 5mg film-coated tablets
zentiva - rosuvastatin calcium - film-coated tablets - 5.2mg - hmg-coa reductase inhibitors - treatment of hypercholesterolaemia adults, adolescents and children aged 6 years or older with primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate. prevention of cardiovascular events prevention of major cardiovascular events in patients who are estimated to have a high risk for a first cardiovascular event (see section 5.1), as an adjunct to correction of other risk factors.
rosuvastatin 10mg film-coated tablets
zentiva - rosuvastatin calcium - film-coated tablets - 10.4mg - hmg-coa reductase inhibitors - treatment of hypercholesterolaemia adults, adolescents and children aged 6 years or older with primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate. prevention of cardiovascular events prevention of major cardiovascular events in patients who are estimated to have a high risk for a first cardiovascular event (see section 5.1), as an adjunct to correction of other risk factors.
rosuvastatin 20mg film-coated tablets
zentiva - rosuvastatin calcium - film-coated tablets - 20.8mg - hmg-coa reductase inhibitors - adults, adolescents and children aged 6 years or older with primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate
rosuvastatin 40mg film-coated tablets
zentiva - rosuvastatin calcium - film-coated tablets - 41.6mg - hmg-coa reductase inhibitors - treatment of hypercholesterolaemia adults, adolescents and children aged 6 years or older with primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate. prevention of cardiovascular events prevention of major cardiovascular events in patients who are estimated to have a high risk for a first cardiovascular event (see section 5.1), as an adjunct to correction of other risk factors.
trazodone 50mg capsules
zentiva pharma uk ltd - trazodone hydrochloride - oral capsule - 50mg
trazodone 100mg capsules
zentiva pharma uk ltd - trazodone hydrochloride - oral capsule - 100mg
trazodone 150mg tablets
zentiva pharma uk ltd - trazodone hydrochloride - oral tablet - 150mg
citalopram 10mg tablets
zentiva pharma uk ltd - citalopram hydrobromide - oral tablet - 10mg
citalopram 20mg tablets
zentiva pharma uk ltd - citalopram hydrobromide - oral tablet - 20mg
citalopram 40mg tablets
zentiva pharma uk ltd - citalopram hydrobromide - oral tablet - 40mg